HOME >> MEDICINE >> NEWS
'Temp doctors' choose career for flexibility, easier lifestyle

But the use of temporary staff doctors appears to be a growing trend, and a new study suggests many doctors are choosing short-term assignments because they don't want to work full-time or because they are seeking a more flexible schedule.

"The most striking finding was this emphasis on a more controllable work schedule and flexibility, especially among women physicians," said Angelo Alonzo, co-author of the study and professor of sociology at Ohio State University.

"If more women physicians seek temporary jobs so they have less stressful lifestyles, it raises issues about the future of health care staffing."

Alonzo conducted the study with Arthur Simon, a physician with the Dean Health System in Madison, Wisc. Their results were published in a recent issue of the Journal of Healthcare Management.

Temporary staff physicians are known as locum tenens (LT), from the Latin "one holding a place." Hospitals, clinics and physician practices hire LTs to cover for vacations, short-term leaves and seasonal demand, as well as other reasons, such as shortages of various specialists.

Although the number of LT physicians is not known for sure, one LT placement firm estimated that 15 percent of all physicians worked locum tenens sometime during their career in 2000, up from 4 percent in 1987 nearly a four-fold increase.

Alonzo and Simon surveyed 776 physicians who worked at least one assignment with CompHealth, an LT placement agency in Salt Lake City. (CompHealth provided the names of those surveyed.)

While about 70 percent of those who responded to the survey were men, the findings suggest women may be particularly drawn to LT jobs, Alonzo said. Women were 30 percent of the LT group, but only account for 23 percent of active U.S. physicians.

For women, the top reason for choosing LT assignments (mentioned by 37 percent) was schedule flexibility.

"Many of the women, as well as some of the men, just don't wa
'"/>

Contact: Angelo Alonzo
Alonzo.1@osu.edu
614-292-6616
Ohio State University
11-Jan-2005


Page: 1 2 3

Related medicine news :

1. Personality tests could predict doctors burnout
2. Unmarried women say they feel misunderstood in doctors offices
3. Addressing medical students as student doctors may help quell patient fears
4. Radical solutions found to meet limits on junior doctors hours
5. Rheumatoid arthritis patients caught in middle of doctors disagreement over hand surgery
6. Breast cancer patients with BRCA 1/2 mutations twice as likely to choose double mastectomy
7. Why do patients choose not to donate tissue?
8. World-first study shows solo mothers choose donor insemination because they lack a partner
9. Lifelong career adds up to top honors for UH math professor
10. Fox Chase Cancer Center and the Girl Scouts partner to promote oncology nursing careers
11. Bad role models lead junior doctors to regret choice of career

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Temp doctors choose career for flexibility easier lifestyle

(Date:5/21/2013)... York (PRWEB) May 21, 2013 The ... Conserve hip replacement lawsuits in U.S. District ... in response to a request from Plaintiffs’ Counsel to ... Defendant. The May 17th Order grants that request, ... be conducted. (In re: Wright Medical Technology, Inc., Conserve ...
(Date:5/21/2013)... MedMar Healing Center announces their participation ... Food Bank. Twenty-eight businesses, including MedMar Healing Center, doctors, and ... The goal is to raise food to help area kids ... families in recent years. , “We like being able ... need,” explains Douglas Chloupek of MedMar Healing Center. “Taking part ...
(Date:5/21/2013)... Defense Serum Repository (DoDSR), University of Cincinnati (UC) researchers ... disease (IBD), which could help with earlier diagnosis and ... , This finding, the first of its kind and ... via podium presentation by staff from Walter Reed National ... held May 18-21 in Orlando, Fla. , The ...
(Date:5/21/2013)... 21, 2013 Today, Zane Benefits, Inc. ... FSA accounts. Zane Benefits, which provides comprehensive and ... the leader in defined contribution and ... , According to Zane Benefits’ website, the Affordable Care ... into law in 2010 and impacts many areas of ...
(Date:5/21/2013)... May 21, 2013 The American Diabetes ... people in the United States of America are affected ... at a great risk of developing peripheral neuropathy which ... lives. The ADA further goes on saying that the ... and around 2 million new cases are diagnosed every ...
Breaking Medicine News(10 mins):Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 2Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 3Health News:San Jose Cannabis Club Helps Feed Hungry Children with Second Harvest Food Bank 2Health News:Biomarkers discovered for inflammatory bowel disease 2Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 2Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 3Health News:Neuracel Aims to Reduce Peripheral Neuropathy Pain 2
(Date:5/21/2013)... N.Y. , May 21, 2013 Sanofi ... (NASDAQ: REGN) today announced that the New England ... 2a study results of dupilumab (SAR231893/REGN668) in patients with ... targeting the alpha subunit of the interleukin 4 receptor ... IL-13, drivers of Th2 (Type 2 helper T cell) ...
(Date:5/21/2013)... May 21, 2013 U.S. spending on specialty ... diseases such as cancer, multiple sclerosis and rheumatoid arthritis ... end of 2015, according to a forecast released today ... http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO ) "As we see ... health plans to act so they can continue to ...
(Date:5/21/2013)... CITY, Calif. , May 21, 2013 ... ACRX ), a specialty pharmaceutical company focused ... therapies for the treatment of acute and ... that in a placebo-controlled Phase 3 study ... (patient-controlled analgesia) System (NanoTab System), the primary ...
Breaking Medicine Technology:Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 2Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 3Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 4Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 5Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 6Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 7U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 2U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 3U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 4U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 5Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 2Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 3Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 4Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 5Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 6Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 7Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 8Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 9Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 10
Cached News: